Sartorius AG

https://www.sartorius.com

LinkedIn: https://www.linkedin.com/company/sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2021, the company earned sales revenue of some 3.45 billion euros. At the end of 2021, nearly 14,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe. *

	Start	1870-01-01 established
	Group	Sartorius (Group)
	Industry	laboratory equipment and instruments
	Industry 2	precision instruments (excl laboratory)
	Person	Kreuzburg, Joachim (Sartorius 200305– CEO)
	Person 2	Lehmann, Rainer (Sartorius 201703–202310 CFO before SVP Business Processes Unit LEFT 11/24)

	Region	Göttingen
	Country	Germany
	Street	20 Otto-Brenner-Str.
	City	37079 Göttingen
	Tel	+49-551-308-0
		Address record changed: 2024-01-05

Basic data	Employees	H: 10,001 to 50,00 (2022-12-31)
	Currency	EUR
	Annual sales	4,174,700,000 (sales revenue, consolidated (2022) 2022-12-31)
	Profit	913,100,000 (2022-12-31)
	Cash	165,900,000 (2022-12-31)

		* Document for »About Section«: Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen.

		Record changed: 2023-12-30